{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T17:34:07Z","timestamp":1785692047430,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ygyno.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T05:50:54Z","timestamp":1633067454000},"page":"557-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy"],"prefix":"10.1016","volume":"163","author":[{"given":"Jessie Y.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Santin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Damast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2021.09.018_bb0010","first-page":"258","article-title":"Current recommendations and recent progress in endometrial cancer","volume":"69","author":"Brooks","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.09.018_bb0015","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"10023","key":"10.1016\/j.ygyno.2021.09.018_bb0020","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.018_bb0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.018_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.018_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.ygyno.2021.09.018_bb0040","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial Cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"7447","key":"10.1016\/j.ygyno.2021.09.018_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research, N","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/cr.2007.115","article-title":"Mechanisms and functions of DNA mismatch repair","volume":"18","author":"Li","year":"2008","journal-title":"Cell Res."},{"issue":"16","key":"10.1016\/j.ygyno.2021.09.018_bb0055","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and Clinicopathological factors in early-stage endometrial Cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.018_bb0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: a prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/annonc\/mdw542","article-title":"Practical guidance for mismatch repair-deficiency testing in endometrial cancer","volume":"28","author":"Stelloo","year":"2017","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.018_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.09.018_bb0080","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.AOG.0000239097.42987.0c","article-title":"Improved survival with an intact DNA mismatch repair system in endometrial cancer","volume":"108","author":"Cohn","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.09.018_bb0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3802\/jgo.2015.26.1.40","article-title":"DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers","volume":"26","author":"Kato","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.018_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2015.11.032","article-title":"Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas","volume":"140","author":"Shikama","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2014.04.053","article-title":"Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type","volume":"134","author":"Ruiz","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2013.03.002","article-title":"Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis","volume":"88","author":"Diaz-Padilla","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.018_bb0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ijgc-2019-000910","article-title":"Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers","volume":"30","author":"Kim","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.018_bb0115","doi-asserted-by":"crossref","first-page":"E457","DOI":"10.1016\/j.ijrobp.2020.07.2572","article-title":"Effect of mismatch repair status on outcome of early stage grade 1-2 endometrial Cancer treated with vaginal brachytherapy","volume":"108","author":"Russo","year":"2020","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"25","key":"10.1016\/j.ygyno.2021.09.018_bb0120","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial Cancer: an NRG oncology\/gynecologic oncology group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.018_bb0125","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djab029","article-title":"Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in endometrial Cancer","volume":"113","author":"Post","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.ygyno.2021.09.018_bb0130","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"26","key":"10.1016\/j.ygyno.2021.09.018_bb0140","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.018_bb0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2019.03.255","article-title":"Immunotherapy and radiation combinatorial trials in gynecologic cancer: a potential synergy?","volume":"154","author":"Lee","year":"2019","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:25Z","timestamp":1758772765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0090825821013913"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}